How the FDA has contributed to mistreatment of pediatric rhinosinusitis.
Poole
M D
MD
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003695:Delivery of Health Care; D005260:Female; D006801:Humans; D008297:Male; D010372:Pediatrics; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents